ABBV vs JNJ — AbbVie Inc. vs Johnson & Johnson Performance & Valuation Comparison
Normalized returns over 2 years plus key valuation and risk snapshots.
QuantSoar AI Verdict
ABBV is the better value pick
ABBV: $264.58 · Margin of Safety -30.0%|JNJ: $271.22 · Margin of Safety -58.4%
Performance & Valuation Comparison
Normalized returns over 2 years plus key valuation and risk snapshots.
Loading performance data...
Fundamentals & Valuation Deep Dive
Side-by-side financial metrics and valuation models.
ABBVMetricJNJ
$264.58Current Price$271.22
86.78Fair Value103.63
-67.2%Margin of Safety-61.8%
74.5P/E Ratio31.5
7.3P/S Ratio6.7
78.8P/B Ratio7.7
0.28Beta0.23
$467.5BMarket Cap$653.6B
0.03%Dividend Yield0.02%
9.8%Profit Margin21.5%
40.0%Operating Margin29.2%
—ROE25.7%
$61.2BRevenue$94.2B
16.3Forward P/E22.3
0.0Debt / Equity57.7
$278.56Analyst Target$277.91
financialProfile
AbbVie Inc.
Current Price$264.58
Fair Value$86.78
Margin of Safety-67.2%
P/E Ratio74.5
P/S Ratio7.3
P/B Ratio-78.8
Beta0.3
Dividend Yield0.03%
Profit Margin9.8%
Operating Margin40.0%
ROE—
Revenue$61.2B
Forward P/E16.3
Debt / Equity—
Analyst Target$278.56
Market Cap$467.5B
financialProfile
Johnson & Johnson
Current Price$271.22
Fair Value$103.63
Margin of Safety-61.8%
P/E Ratio31.5
P/S Ratio6.7
P/B Ratio7.7
Beta0.2
Dividend Yield0.02%
Profit Margin21.5%
Operating Margin29.2%
ROE25.7%
Revenue$94.2B
Forward P/E22.3
Debt / Equity57.7
Analyst Target$277.91
Market Cap$653.6B
Smart Investment Matcher
Input your budget and horizon. We simulate DCA backtests and recommend the best fit.
Loading smart matcher...
Final Verdict & Actionable Takeaways
Our quantitative verdict
ABBV offers better risk-adjusted value
Based on margin of safety (ABBV wins) and beta safety (JNJ wins).
Related Stock Comparisons
Explore other popular side-by-side matchups and sector peers.